Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SOX2 mediates metabolic reprogramming of prostate cancer cells.
de Wet L, Williams A, Gillard M, Kregel S, Lamperis S, Gutgesell LC, Vellky JE, Brown R, Conger K, Paner GP, Wang H, Platz EA, De Marzo AM, Mu P, Coloff JL, Szmulewitz RZ, Vander Griend DJ. de Wet L, et al. Among authors: lamperis s. Oncogene. 2022 Feb;41(8):1190-1202. doi: 10.1038/s41388-021-02157-x. Epub 2022 Jan 24. Oncogene. 2022. PMID: 35067686 Free PMC article.
Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction.
McAuley EM, Mustafi D, Simons BW, Valek R, Zamora M, Markiewicz E, Lamperis S, Williams A, Roman BB, Vezina C, Karczmar G, Oto A, Vander Griend DJ. McAuley EM, et al. Among authors: lamperis s. Am J Pathol. 2017 Nov;187(11):2378-2387. doi: 10.1016/j.ajpath.2017.07.014. Epub 2017 Aug 18. Am J Pathol. 2017. PMID: 28823870 Free PMC article.
Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cells.
de Wet L, Williams A, Gillard M, Kregel S, Lamperis S, Gutgesell LC, Vellky JE, Brown R, Conger K, Paner GP, Wang H, Platz EA, De Marzo AM, Mu P, Coloff JL, Szmulewitz RZ, Vander Griend DJ. de Wet L, et al. Among authors: lamperis s. Oncogene. 2022 Feb;41(8):1234. doi: 10.1038/s41388-022-02228-7. Oncogene. 2022. PMID: 35145235 No abstract available.
SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis.
Williams A, Gutgesell L, de Wet L, Selman P, Dey A, Avineni M, Kapoor I, Mendez M, Brown R, Lamperis S, Blajszczak C, Bueter E, Kregel S, Vander Griend DJ, Szmulewitz RZ. Williams A, et al. Among authors: lamperis s. Cancer Lett. 2023 Jul 1;565:216209. doi: 10.1016/j.canlet.2023.216209. Epub 2023 May 9. Cancer Lett. 2023. PMID: 37169162 Free article.